Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NSAID2015: Effects of COX-inhibiting Drugs on Muscle Adaptations
NCT02531451Phase 2Completed
- Sponsor
- Karolinska Institutet
- Start
- Sep 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of ibuprofen (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Change in Quadriceps muscle volume at 8 weeks. Started Sep 2015; status: completed.
02
Drugs
ibuprofen
Beyond the preview
Go deeper on NCT02531451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02531451.